# HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?

> **NCT02631980** · PHASE3 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 50 (actual)

## Conditions studied

- Anemia
- Postoperative Blood Loss

## Interventions

- **DRUG:** IV iron
- **DRUG:** IV placebo

## Key facts

- **NCT ID:** NCT02631980
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02631980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02631980, "HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02631980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*